BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 7987114)

  • 1. Over the counter H2 receptor antagonists. Serve only as expensive antacids.
    Douds AC; Maxwell JD
    BMJ; 1994 Oct; 309(6962):1156. PubMed ID: 7987114
    [No Abstract]   [Full Text] [Related]  

  • 2. Over-the-counter histamine H2-receptor antagonists. How will they affect the treatment of acid-related diseases?
    Holt S
    Drugs; 1994 Jan; 47(1):1-11. PubMed ID: 7510616
    [No Abstract]   [Full Text] [Related]  

  • 3. Dyspepsia and reflux in primary care: rough DIAMOND of a trial.
    van Zanten SV
    Lancet; 2009 Jan; 373(9659):187-8. PubMed ID: 19150689
    [No Abstract]   [Full Text] [Related]  

  • 4. [H2 blockers and antacids in gastrointestinal diseases].
    Stein J; Rösch W
    Pharm Unserer Zeit; 2007; 36(1):38-43. PubMed ID: 17283749
    [No Abstract]   [Full Text] [Related]  

  • 5. Meta-analysis: the efficacy of over-the-counter gastro-oesophageal reflux disease therapies.
    Tran T; Lowry AM; El-Serag HB
    Aliment Pharmacol Ther; 2007 Jan; 25(2):143-53. PubMed ID: 17229239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Over the counter sales of histamine-2 receptor antagonists.
    Petersen H
    Scand J Gastroenterol Suppl; 1988; 155():20-2. PubMed ID: 2907682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Current principles of treatment of acid-dependent diseases].
    Maev IV; V'iuchnova ES; Grishchenko EB
    Klin Med (Mosk); 2003; 81(1):56-62. PubMed ID: 12650099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dyspepsia responsive to acid suppression therapy: reflux disease or duodenal hypersensitivity?
    Smout AJ
    Dig Liver Dis; 2000 Dec; 32 Suppl 3():S258-60. PubMed ID: 11245313
    [No Abstract]   [Full Text] [Related]  

  • 9. [Self-medication in gastroesophageal reflux: role and limits].
    De Winter B; Guillemot F
    Gastroenterol Clin Biol; 1999 Jan; 23(1 Pt 2):S297-301. PubMed ID: 10078459
    [No Abstract]   [Full Text] [Related]  

  • 10. [Medical treatment of gastroesophageal reflux by H2 receptor antagonists].
    Scarpignato C; Bruley des Varannes S
    Gastroenterol Clin Biol; 1999 Jan; 23(1 Pt 2):S78-89. PubMed ID: 10078436
    [No Abstract]   [Full Text] [Related]  

  • 11. Nonprescription Heartburn Medications for Adults.
    Vordenberg SE
    JAMA; 2023 Oct; 330(15):1499. PubMed ID: 37773509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Habit, prejudice, power and politics: issues in the conversion of H2-receptor antagonists to over-the-counter use.
    Hunt RH
    CMAJ; 1996 Jan; 154(1):49-53. PubMed ID: 8542566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Over-the-counter H2-receptor antagonists for heartburn.
    Med Lett Drugs Ther; 1995 Oct; 37(960):95-6. PubMed ID: 7565298
    [No Abstract]   [Full Text] [Related]  

  • 14. The medical management of reflux esophagitis. Role of antacids and acid inhibition.
    Sontag SJ
    Gastroenterol Clin North Am; 1990 Sep; 19(3):683-712. PubMed ID: 1977703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. H2-receptor antagonists.
    Nurs Times; 2004 Nov 2-8; 100(44):33. PubMed ID: 15552489
    [No Abstract]   [Full Text] [Related]  

  • 16. Partnership in optimizing management of reflux symptoms: a treatment algorithm for over-the-counter proton-pump inhibitors.
    Boardman HF; Delaney BC; Haag S
    Curr Med Res Opin; 2015; 31(7):1309-18. PubMed ID: 25950642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Update on current care guidelines. A current care guideline: recurrent upper gastrointestinal symptoms].
    Paikka N
    Duodecim; 2012; 128(22):2376-7. PubMed ID: 23342484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease.
    Hatlebakk JG; Berstad A
    Clin Pharmacokinet; 1996 Nov; 31(5):386-406. PubMed ID: 9118586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The risks and benefits of an Rx-to-OTC switch. The case of over-the-counter H2-blockers.
    Oster G; Huse DM; Delea TE; Colditz GA; Richter JM
    Med Care; 1990 Sep; 28(9):834-52. PubMed ID: 1976142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonprescription H2-receptor antagonists.
    Marsh TD
    J Am Pharm Assoc (Wash); 1997; NS37(5):552-6. PubMed ID: 9479407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.